ARCHIVES

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

This article is from The Cancer Letter archive.

Vol. 29 No. 38 | October 17, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation

March 13, 2009

DCT board Okays Recompetition of Clinical Trials Contracts

October 29, 1993

In Brief: Knowledge Surgeons, Radiotherapists, Pathologists Untapped, Zubrod Suggests

February 20, 1976

Budget Cut Asked By Ford Would Hold Grant Funding To 20%

January 10, 1975

DCT Board Approves Concepts For New CTEP, RRP Grants

February 24, 1989

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

January 2, 1981